/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Discussion and audience interaction
Event: ESC Congress 2023
Topic: Valvular Heart Disease
Session: Aortic stenosis journey: where do we stand and where is the future taking us?
Which aortic stenosis patients are we not optimally treating?
Event: ESC Congress 2023
Topic: Valvular Heart Disease
Session: Aortic stenosis journey: where do we stand and where is the future taking us?
Discussion - What challenges do we need to tackle in the future?
Event: ESC Congress 2022
Topic: Treatment
Session: 20 years of TAVI - How can we get to a comprehensive patient management?
Putting severe aortic stenosis patient management into practice.
Event: ESC Congress 2022
Topic: Treatment
Session: 20 years of TAVI - How can we get to a comprehensive patient management?
2021 ESC/EACTS VHD guidelines: evolution of treatment recommendations.
Event: ESC Congress 2021 - The Digital Experience
Topic: Aortic Valve Stenosis
Session: The Future of TAVI: How are the new 2021 ESC/EACTS VHD guidelines changing management and treatment of patients with aortic stenosis
Discussion - Patient selection for protected PCI: who benefits most?
Event: ESC Congress 2019
Topic: Treatment
Session: Recovering hearts - Saving lives
Reclassification of aortic valve stenosis patients by integration of computed tomography parameters into the echocardiographically assessed continuity equation
Event: ESC Congress 2017
Topic: Aortic valve disease
Session: Multimodality imaging in aortic stenosis
Hemodynamic stabilization to facilitate complete revascularization.
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Miscellaneous
Session: How innovative percutaneous Ventricular Assist Device (pVAD) systems improve outcomes in cardiogenic shock and facilitate complete revascularization in high risk Percutaneous Coronary Intervention (PCI) patients
Next generation transcatheter heart valves improve clinical outcomes in patients undergoing transcatheter aortic valve implantation.
Event: ESC Congress 2016
Topic: Surgery and intervention in valve disease
Session: Valvular disease
Transcatheter aortic valve replacement with the self-expanding CoreValve prosthesis performed using clinical best practices: impact on clinical outcomes to six months. The ADVANCE II study.
Event: ESC Congress 2016
Topic: Surgery and intervention in valve disease
Session: Aortic valve disease
ESC 365 is supported by
